Role of baricitinib in COVID-19 patients: A systematic review and meta-analysis

Table 2 Characteristics of included clinical trials

Ref.	Country	Study design	Sample size	Sex		Baricitinib group		Non-baricitinib group
				Male	Female	Number of patients	Death	Number of patients	Death
Bronte et al[13], 2020	Italy	Clinical trial	76	38	38	20	1	56	25
Kalil et al[12], 2020	Omaha	Clinical trial	1033	652	381	515	32	518	52
Cantini et al[17], 2020	Germany	Clinical trial	24	20	4	12	0	12	0
Cantini et al[18], 2020	Italy	Clinical trial	191	119	72	113	0	78	7
Cao et al[20],2020	Wuhan	Clinical trial	41	24	17	20	0	21	3
D'Alessio et al[21],2021	Italy	Clinical trial	75	52	23	32	3	43	0
Giudice et al[22], 2020	Italy	Clinical trial	17	13	4	7	1	10	1